ArticleNature2021
Rich countries should tithe their vaccines.
Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis.Frontiers in public health · 2022Pooled it
- Overcoming barriers to medical countermeasures: Strengthening global biosecurity.Human vaccines & immunotherapeutics · 2025Review
- Global health 2050: the path to halving premature death by mid-century.Lancet (London, England) · 2024Review
- COVID-19 vaccine hesitancy and conspiracy beliefs in Togo: Findings from two cross-sectional surveys.PLOS global public health · 2024Article
- Climate Justice and the Duty of Restitution.Moral philosophy and politics · 2023Article
- Ensuring COVID-19 vaccines for low-income countries.Journal of public health (Oxford, England) · 2022Article
- It is not too late to achieve global covid-19 vaccine equity.BMJ (Clinical research ed.) · 2022Article
- Strategies for COVID-19 vaccination under a shortage scenario: a geo-stochastic modelling approach.Scientific reports · 2022Article
- CanMolecules (Basel, Switzerland) · 2022Article
- Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries.Applied health economics and health policy · 2022Article
- Vaccine third dose and cancer patients: necessity or luxury?ESMO open · 2021Review
- Analysing the Launch of COVID-19 Vaccine National Rollouts: Nine Case Studies.Epidemiologia (Basel, Switzerland) · 2021Article
- The East-West Divide in Response to COVID-19.Engineering (Beijing, China) · 2021Article
- COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation.Infectious disease reports · 2021Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
33627806What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.